Believers in haematological destiny would be intrigued to know that Cristóbal Frutos was born on May 28, which is World Blood Cancer Day. Still a few years younger than 40 years, he is the transplant ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into optimising anti-CD38 antibody-containing quadruplet regimens (quads) for ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The International Agency for Research on Cancer predicts more than 35 million new cancer cases in 2050, a 77% increase from 2022. The greatest burden will fall on low-income and middle-income ...

Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our study highlights the need for future studies that identify possible causal ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...